worldwide locations | contacts | sitemap

 

 

 

 

About Novartis

NIBR in the News

2010

June 7, 2010
Research Recalibrated
by Lisa M. Jarvis

May 20, 2010
DIVERSITYINC: Top 10 Companies for Global Diversity
by Barbara Frankel

May 20, 2010
Ghanaian Pharmacist to Roll out new Cancer Drug
by Ghana News Agency

May 17, 2010
For Novartis Cambridge is a Growth Site
by Robert Weisman

May 3, 2010
Big Pharma Comes To Town
When in Cambridge, major drug companies play by Cambridge rules in a quest for breakthroughs
By Rick Mullin

May 3, 2010
Novartis Postdoc Program Takes An Academic Track
Researchers gaining exposure to industrial science are encouraged to publish
By Rick Mullin

April 30, 2010
Promise Seen in Drug for Retardation Syndrome
By Gardiner Harris

April 13, 2010
Novartis moves closer to first oral MS treatment
by Katie Reid

March 25, 2010
Novartis Beats Rush Hour with Flex-Hours
By Christine Cignoli, Special to Mass High Tech

March 15, 2010
Outwitting germs that never say die - Persister cells baffle, intrigue researchers
By Carolyn Y. Johnson - Boston Globe Staff

March 8, 2010
Town Hall Meeting Predicts Chemistry's Future
By Amanda T. Yarnell - ACS News

February 2, 2010
AUC Graduate Student Creates Advanced Device for Allergy Testing
AUC Now

January 2010
NIBR Touts Promising Drugs, Lab of Future
By Christiane Truelove, PharmaLive

 

Clinical sciences

Incorporating clinical medicine into its early stage "benchtop" drug discovery...

Disease areas

Understanding the underlying molecular basis of disease has enabled NIBR to turn scientific insights into medical breakthroughs.